sdb scott ballantyne subject burzynski antineoplastons article jschwimmer josh schwimmer write opinion burzynski antineoplastons information current status research would appreciate burzynski work promise none antineoplastons show antineoplastic effect experimental cancer nci conduct test leukemia mouse result high enough produce toxic effect mouse effective inhibit growth tumor kill burzynski claim active factor common something ha show ha extract also ha show actually distinct substance nci conduct series test use standard panel tumor include different cell line tumor follow class leukemia non-small-cell small-cell lung cancer colon cancer cancer central nervous system melanoma ovarian cancer renal cancer exhibit neither growth inhibition cytotoxicity dose level test necessary process since soluble burzynski theory require soluble agent basically hydrolize pag call pag information carry peptide something byrzynski claim necessary antineoplastic activity also derive mixture pa pag pa also peptide purchase chemical supply house gram chemically extremely similar glutithamide thalidomide habit form cause peripheral neuropathy nasty effect thalidomide widely know spite similarity doe appear test potential induce teratogenicity peripheral neuropathy many burzynski statement origin theory early research past present support others work show untrue sdb sdb 